These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19796522)

  • 1. About colchicine compliance, resistance and virulence.
    Ben-Chetrit E; Aamar S
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S1-3. PubMed ID: 19796522
    [No Abstract]   [Full Text] [Related]  

  • 2. The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever.
    Bezalel Y; Gershoni-Baruch R; Dagan E; Lidar M; Livneh A
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S103-4. PubMed ID: 19796545
    [No Abstract]   [Full Text] [Related]  

  • 3. Leucopenia resoluted with colchicine in familial mediterranean Fever.
    Sakallioglu O
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):162. PubMed ID: 22031120
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.
    Ozen F; Silan C; Uludag A; Candan F; Silan F; Ozdemir S; Atik S; Ozdemir O
    Ren Fail; 2011; 33(9):899-903. PubMed ID: 21851199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Infliximab in colchicine resistant familial Mediterranean fever.
    Antón Vázquez V; Güell Farré E; Corominas H
    Med Clin (Barc); 2017 Dec; 149(11):510-511. PubMed ID: 28756998
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients.
    Akbaba TH; Ustabas G; Kasap-Cuceloglu M; Ozen S; Balci-Peynircioglu B
    Mol Biol Rep; 2020 Nov; 47(11):9005-9011. PubMed ID: 33161498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
    Ozkan S; Atas B
    J Pak Med Assoc; 2017 Jun; 67(6):945-947. PubMed ID: 28585601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female reproductive dysfunction in familial Mediterranean fever patients with and without colchicine treatment.
    Cerquaglia C; Verrecchia E; Fonnesu C; Giovinale G; Marinaro A; de Socio G; Manna R
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S101. PubMed ID: 20868586
    [No Abstract]   [Full Text] [Related]  

  • 9. [Periodic disease in a patient with admittance diagnosis yersiniosis].
    Shestakova IV; Iushchuk ND; Popova TI
    Ter Arkh; 2006; 78(11):78-80. PubMed ID: 17195534
    [No Abstract]   [Full Text] [Related]  

  • 10. Infantile colitis as a novel presentation of familial Mediterranean fever responding to colchicine therapy.
    Egritas O; Dalgic B
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):102-5. PubMed ID: 21694544
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of familial Mediterranean fever with emphasis on pyrin and colchicine.
    Dbouk HA; Uthman IW
    J Med Liban; 2008; 56(1):35-41. PubMed ID: 19534089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients.
    Uludag A; Silan C; Atik S; Akurut C; Uludag A; Silan F; Ozdemir O
    Genet Test Mol Biomarkers; 2014 Feb; 18(2):73-6. PubMed ID: 24180297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine and ocular surface changes in familial Mediterranean fever.
    Lazar M; Rothkoff L
    Acta Ophthalmol; 2010 Mar; 88(2):e5; author reply e6. PubMed ID: 19681787
    [No Abstract]   [Full Text] [Related]  

  • 14. PHOTO QUIZ. Recurrent buttock cellulitis in a female adolescent.
    Kanj SS; Sharara AI
    Clin Infect Dis; 2014 May; 58(9):1273, 1338. PubMed ID: 24723579
    [No Abstract]   [Full Text] [Related]  

  • 15. Colchicine myopathy and neuromyopathy: two cases with different characteristics.
    Cantarini L; Volpi N; Galeazzi M; Giani T; Fanti F; Lucherini OM; Aglianò M; Alessandrini C; Giannini F; Magi S; Greco G; Baldari CT; Cimaz R
    J Clin Rheumatol; 2010 Aug; 16(5):229-32. PubMed ID: 20661070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
    Gül A; Ozdogan H; Erer B; Ugurlu S; Kasapcopur O; Davis N; Sevgi S
    Arthritis Res Ther; 2015 Sep; 17(1):243. PubMed ID: 26337145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine.
    Rozenbaum M; Boulman N; Feld J; Avshovich N; Petrovich S; Elias M; Slobodin G; Rosner I
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S105. PubMed ID: 19796546
    [No Abstract]   [Full Text] [Related]  

  • 18. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?
    Sönmez HE; Esmeray P; Batu ED; Arıcı ZS; Demir S; Sağ E; Özen S; Bilginer Y
    Rheumatol Int; 2019 Jan; 39(1):83-87. PubMed ID: 30088045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation?
    Ozen S
    Arthritis Rheum; 2009 Jun; 60(6):1575-7. PubMed ID: 19479854
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.
    Tufan A; Babaoglu MO; Akdogan A; Yasar U; Calguneri M; Kalyoncu U; Karadag O; Hayran M; Ertenli AI; Bozkurt A; Kiraz S
    J Rheumatol; 2007 Jul; 34(7):1540-4. PubMed ID: 17610314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.